P-55 Collaborative development of diabetes screening and management guidelines in Guyana

Methods: This initiative employed a collaborative design involving the Family Medicine Service Line at Northwell Health, Zucker School of Medicine, and the Family Medicine Residency Program at Georgetown Public Hospital. Methods included extensive literature reviews, critical analysis of local health data through consultation with incountry medical professionals, and iterative feedback from Guyanese primary care clinicians. The guidelines were developed to reflect available diagnostic tools and medications in Guyana, emphasizing accessibility and affordability.

Results: The collaborative process yielded updated clinical treatment guidelines tailored for Guyana. Key recommendations include broadened screening criteria for all individuals aged 18 and above, specific criteria for those under 18 with risk factors (e.g., BMI > 95th percentile, early-onset family history), and all pregnant persons. Screening methods incorporate blood tests (Fasting Blood Glucose, HbA1c) and urine tests. Medication protocols were enhanced to include advanced options like GLP-1 receptor agonists and SGLT2 inhibitors for specific complications, alongside culturally relevant lifestyle modifications, all while considering medication availability and affordability in Guyana.

Conclusion: These updated guidelines provide a comprehensive, equitable, and locally adaptable framework for diabetes care in Guyana. Their focus on early detection, tailored interventions, and accessible treatments is crucial for reducing the burden of diabetes and enhancing patient outcomes, pending adoption by the Ministry of Health and subsequent dissemination and clinician training.